LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage
European Journal of Pharmacology · 2024
DOI: 10.1016/j.ejphar.2023.176201 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2024. Verfasst von Xiaohong Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, China; Dep…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hunan Province of China.
Abstract (Originalsprache)
Multiple sclerosis (MS) is an inflammatory demyelinating disease in the central nervous system caused by T cell activation mediated by peripheral macrophages, resulting in severe neurological deficits and disability. Due to the currently limited and expensive treatments for MS, we here introduce an economic Chinese medicine extract, (5R)-5-Hydroxytriptolide (LLDT-8), which shows low toxicity and high immunosuppressive activity. We used the widely accepted mouse model of MS, experimental autoimmune encephalomyelitis (EAE), to examine the immunosuppressive effect of LLDT-8 in vivo. Through the RNA-sequence analysis of peripheral macrophages in EAE mice, we discovered that LLDT-8 alleviates the symptoms of EAE by inhibiting the proinflammatory effect of macrophages, thereby blocking the activation and proliferation of T cells. In all, we found that LLDT-8 could be a potential treatment for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, China; Department of Neurology, Drum Tower Hospital, Medical School and the Stat…
- Department of Neurology, Drum Tower Hospital, Medical School and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, 210008, China; Center for Rehabilitation Medicine, Departm…
- Department of Neurology, Drum Tower Hospital, Medical School and the State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, Jiangsu, 210008, China; Jiangsu Key Laboratory for Molecular Medici…
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Hunan Province of China
Zitieren
APA
Dong, X., Zhu, L. W., Zhang, Z., Cao, R., Liu, P., Shu, X., Cao, X., Hu, Y., Bao, X., Xu, L., Li, C., & Xu, Y. (2024). LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2023.176201
Vancouver
Dong X, Zhu LW, Zhang Z, Cao R, Liu P, Shu X, et al. LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage. European Journal of Pharmacology. 2024. doi:10.1016/j.ejphar.2023.176201
BibTeX
@article{Dong2024,
author = {Dong, Xiaohong and Zhu, Li-Wen and Zhang, Zhi and Cao, Runjing and Liu, Pinyi and Shu, Xin and Cao, Xiang and Hu, Yujie and Bao, Xinyu and Xu, Lushan and Li, Chenggang and Xu, Yun},
title = {LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage},
journal = {European Journal of Pharmacology},
year = {2024},
doi = {10.1016/j.ejphar.2023.176201}
}
EUVIMED